Global and United States Patient Risk Capital Investment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Patient Risk Capital Investment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Early Stage Financing
  • 1.2.3 Expansion Financing
  • 1.2.4 Acquisition or Buyout Financing
• 1.3 Market by Application
  • 1.3.1 Global Patient Risk Capital Investment Market Share by Application: 2020 VS 2026
  • 1.3.2 High Technology Industries
  • 1.3.3 Innovative Technology Company
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Patient Risk Capital Investment Market Perspective (2015-2026)
• 2.2 Global Patient Risk Capital Investment Growth Trends by Regions
  • 2.2.1 Patient Risk Capital Investment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Patient Risk Capital Investment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Patient Risk Capital Investment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Patient Risk Capital Investment Players by Market Size
  • 3.1.1 Global Top Patient Risk Capital Investment Players by Revenue (2015-2020)
  • 3.1.2 Global Patient Risk Capital Investment Revenue Market Share by Players (2015-2020)
• 3.2 Global Patient Risk Capital Investment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Patient Risk Capital Investment Revenue
• 3.4 Global Patient Risk Capital Investment Market Concentration Ratio
  • 3.4.1 Global Patient Risk Capital Investment Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Patient Risk Capital Investment Revenue in 2019
• 3.5 Key Players Patient Risk Capital Investment Area Served
• 3.6 Key Players Patient Risk Capital Investment Product Solution and Service
• 3.7 Date of Enter into Patient Risk Capital Investment Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Patient Risk Capital Investment Breakdown Data by Type (2015-2026)

• 4.1 Global Patient Risk Capital Investment Historic Market Size by Type (2015-2020)
• 4.2 Global Patient Risk Capital Investment Forecasted Market Size by Type (2021-2026)

5 Patient Risk Capital Investment Breakdown Data by Application (2015-2026)

• 5.1 Global Patient Risk Capital Investment Historic Market Size by Application (2015-2020)
• 5.2 Global Patient Risk Capital Investment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Patient Risk Capital Investment Market Size (2015-2026)
• 6.2 North America Patient Risk Capital Investment Market Size by Type (2015-2020)
• 6.3 North America Patient Risk Capital Investment Market Size by Application (2015-2020)
• 6.4 North America Patient Risk Capital Investment Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Patient Risk Capital Investment Market Size (2015-2026)
• 7.2 Europe Patient Risk Capital Investment Market Size by Type (2015-2020)
• 7.3 Europe Patient Risk Capital Investment Market Size by Application (2015-2020)
• 7.4 Europe Patient Risk Capital Investment Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Patient Risk Capital Investment Market Size (2015-2026)
• 8.2 China Patient Risk Capital Investment Market Size by Type (2015-2020)
• 8.3 China Patient Risk Capital Investment Market Size by Application (2015-2020)
• 8.4 China Patient Risk Capital Investment Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Patient Risk Capital Investment Market Size (2015-2026)
• 9.2 Japan Patient Risk Capital Investment Market Size by Type (2015-2020)
• 9.3 Japan Patient Risk Capital Investment Market Size by Application (2015-2020)
• 9.4 Japan Patient Risk Capital Investment Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Patient Risk Capital Investment Market Size (2015-2026)
• 10.2 Southeast Asia Patient Risk Capital Investment Market Size by Type (2015-2020)
• 10.3 Southeast Asia Patient Risk Capital Investment Market Size by Application (2015-2020)
• 10.4 Southeast Asia Patient Risk Capital Investment Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Accel
  • 11.1.1 Accel Company Details
  • 11.1.2 Accel Business Overview
  • 11.1.3 Accel Patient Risk Capital Investment Introduction
  • 11.1.4 Accel Revenue in Patient Risk Capital Investment Business (2015-2020))
  • 11.1.5 Accel Recent Development
• 11.2 Benchmark Capital
  • 11.2.1 Benchmark Capital Company Details
  • 11.2.2 Benchmark Capital Business Overview
  • 11.2.3 Benchmark Capital Patient Risk Capital Investment Introduction
  • 11.2.4 Benchmark Capital Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.2.5 Benchmark Capital Recent Development
• 11.3 First Round Capital
  • 11.3.1 First Round Capital Company Details
  • 11.3.2 First Round Capital Business Overview
  • 11.3.3 First Round Capital Patient Risk Capital Investment Introduction
  • 11.3.4 First Round Capital Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.3.5 First Round Capital Recent Development
• 11.4 Lowercase Capital
  • 11.4.1 Lowercase Capital Company Details
  • 11.4.2 Lowercase Capital Business Overview
  • 11.4.3 Lowercase Capital Patient Risk Capital Investment Introduction
  • 11.4.4 Lowercase Capital Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.4.5 Lowercase Capital Recent Development
• 11.5 Sequoia Capital
  • 11.5.1 Sequoia Capital Company Details
  • 11.5.2 Sequoia Capital Business Overview
  • 11.5.3 Sequoia Capital Patient Risk Capital Investment Introduction
  • 11.5.4 Sequoia Capital Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.5.5 Sequoia Capital Recent Development
• 11.6 UNION SQUARE VENTURES
  • 11.6.1 UNION SQUARE VENTURES Company Details
  • 11.6.2 UNION SQUARE VENTURES Business Overview
  • 11.6.3 UNION SQUARE VENTURES Patient Risk Capital Investment Introduction
  • 11.6.4 UNION SQUARE VENTURES Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.6.5 UNION SQUARE VENTURES Recent Development
• 11.7 Andreessen Horowitz
  • 11.7.1 Andreessen Horowitz Company Details
  • 11.7.2 Andreessen Horowitz Business Overview
  • 11.7.3 Andreessen Horowitz Patient Risk Capital Investment Introduction
  • 11.7.4 Andreessen Horowitz Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.7.5 Andreessen Horowitz Recent Development
• 11.8 Bessemer Venture Partners
  • 11.8.1 Bessemer Venture Partners Company Details
  • 11.8.2 Bessemer Venture Partners Business Overview
  • 11.8.3 Bessemer Venture Partners Patient Risk Capital Investment Introduction
  • 11.8.4 Bessemer Venture Partners Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.8.5 Bessemer Venture Partners Recent Development
• 11.9 Greylock Partners
  • 11.9.1 Greylock Partners Company Details
  • 11.9.2 Greylock Partners Business Overview
  • 11.9.3 Greylock Partners Patient Risk Capital Investment Introduction
  • 11.9.4 Greylock Partners Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.9.5 Greylock Partners Recent Development
• 11.10 Kleiner Perkins Caufield & Byers
  • 11.10.1 Kleiner Perkins Caufield & Byers Company Details
  • 11.10.2 Kleiner Perkins Caufield & Byers Business Overview
  • 11.10.3 Kleiner Perkins Caufield & Byers Patient Risk Capital Investment Introduction
  • 11.10.4 Kleiner Perkins Caufield & Byers Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 11.10.5 Kleiner Perkins Caufield & Byers Recent Development
• 11.11 Baseline Ventures
  • 10.11.1 Baseline Ventures Company Details
  • 10.11.2 Baseline Ventures Business Overview
  • 10.11.3 Baseline Ventures Patient Risk Capital Investment Introduction
  • 10.11.4 Baseline Ventures Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 10.11.5 Baseline Ventures Recent Development
• 11.12 Breyer Capital
  • 10.12.1 Breyer Capital Company Details
  • 10.12.2 Breyer Capital Business Overview
  • 10.12.3 Breyer Capital Patient Risk Capital Investment Introduction
  • 10.12.4 Breyer Capital Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 10.12.5 Breyer Capital Recent Development
• 11.13 Founders Fund
  • 10.13.1 Founders Fund Company Details
  • 10.13.2 Founders Fund Business Overview
  • 10.13.3 Founders Fund Patient Risk Capital Investment Introduction
  • 10.13.4 Founders Fund Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 10.13.5 Founders Fund Recent Development
• 11.14 Index Ventures
  • 10.14.1 Index Ventures Company Details
  • 10.14.2 Index Ventures Business Overview
  • 10.14.3 Index Ventures Patient Risk Capital Investment Introduction
  • 10.14.4 Index Ventures Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 10.14.5 Index Ventures Recent Development
• 11.15 New Enterprise Associates
  • 10.15.1 New Enterprise Associates Company Details
  • 10.15.2 New Enterprise Associates Business Overview
  • 10.15.3 New Enterprise Associates Patient Risk Capital Investment Introduction
  • 10.15.4 New Enterprise Associates Revenue in Patient Risk Capital Investment Business (2015-2020)
  • 10.15.5 New Enterprise Associates Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer